Yosuke Komatsu Society of Obstetric Medicine of Australia and New Zealand ASM 2023

Yosuke Komatsu

Abstracts this author is presenting:

• Safety and efficacy of nipocalimab in pregnant individuals at high risk for early-onset severe hemolytic disease of the fetus and newborn: results from the phase 2 UNITY study — SESSION 2 - Free Communications
• Design of a phase 3 study of nipocalimab in pregnancies at risk for severe hemolytic disease of the fetus and newborn — LUNCH, POSTER VIEWING and TRAINEE MEET AND GREET
• Clinical Outcomes of Current Standard-of-Care in Pregnant Participants and Their Offspring at High Risk of Early-Onset Severe Hemolytic Disease of the Fetus and Newborn: Results from the Prospective Observational CLARITY Study — LUNCH, POSTER VIEWING and TRAINEE MEET AND GREET